Printer Friendly

SCHNEIDER BEGINS MARKETING PTCA OVER-THE-WIRE BALLOON CATHETER

 NEW YORK, May 5 /PRNewswire/ -- Schneider (USA) Inc., a unit of the Hospital Products Group of Pfizer Inc (NYSE: PFE), said today it has begun marketing the first laser-bonded PTCA(A) over-the-wire balloon catheter following review by the Food and Drug Administration.
 The balloon catheter, called MYSTIC(B), uses the patent-pending LightTrac(C) laser bonding process developed by Schneider as well as new non-compliant balloon material technology, said Schneider President Joseph E. Laptewicz, Jr. MYSTIC features superior trackability and wire motion in a non-compliant, over-the-wire system, Mr. Laptewicz said.
 Currently in limited use in selected hospitals across the United States, MYSTIC will be available for national distribution within a month. This new product significantly broadens Schneider's product offerings to interventional cardiologists. These now include high- performance over-the-wire and rapid exchange PTCA balloons, guide catheters, diagnostic catheters and diagnostic and specialty guidewires. U.S. industry sales of vascular catheters used in angioplasty procedures is estimated at more than $400 million annually.
 Headquartered in Plymouth, Minn., Schneider (USA) is a leader in advanced angioplasty and angiography products. Pfizer Inc is a diversified, research-based health care company with global operations. Pfizer reported sales of $7.23 billion for 1992.
 NOTES:
 (A) Percutaneous Transluminal Coronary Angioplasty.
 (B) MYSTIC is a registered Pfizer trademark.
 (C) LightTrac is a registered Pfizer trademark.
 -0- 5/5/93
 /Andy McCormick, 212-573-1226, or A.A.Biesada, 212-573-2055, both of Pfizer/
 (PFE)


CO: Pfizer Inc; Schneider (USA) Inc. ST: New York, Minnesota IN: HEA SU: PDT

SH -- NY074 -- 4990 05/05/93 15:17 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 5, 1993
Words:255
Previous Article:HINGHAM INSTITUTE FOR SAVINGS ANNOUNCES DISSIDENT SLATE
Next Article:BAROID CORPORATION ANNOUNCES SECOND QUARTER DIVIDEND
Topics:


Related Articles
SCIMED ANNOUNCES NEW PRODUCT
SCHNEIDER'S LASER-WELDED BALLOON CATHETER APPROVED FOR MARKETING BY FDA
SCIMED ANNOUNCES INTRODUCTION OF HIGH-PERFORMANCE, NON-COMPLIANT PTCA BALLOON CATHETER AND ITS FIRST CORONARY GUIDE WIRE
TWO NEW CORDIS ANGIOPLASTY CATHETERS GAIN U.S. MARKET RELEASE
SCHNEIDER BEGINS MARKETING NEW DIAGNOSTIC CATHETERS
FOUR CORDIS ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
SCIMED ANNOUNCES NEW PTCA GUIDE WIRE SYSTEM
SCHNEIDER BEGINS MARKETING BALLOON CATHETER 'FREEHAND'
SCHNEIDER LAUNCHES THREE NEW BALLOON CATHETERS
SCIMED DISPLAYS FIVE NEW DEVICES AT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters